Ibere Pharmaceuticals Net Tangible Assets

Ibere Pharmaceuticals (IBER) currently reports a net tangible assets of $130M as of September 2022. That compares with $130M in the prior-year period — up 4.9% year over year. Use the charts on this page to explore Ibere Pharmaceuticals's net tangible assets history and peer comparisons.

Ibere Pharmaceuticals's net tangible assets increased from $130M to $130M — a 4.9% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ibere Pharmaceuticals reported $130M in net tangible assets as of September 2022. That compares with $130M in the prior-year period — up 4.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ibere Pharmaceuticals, and consider following IBER for alerts when major investors trade the stock.